Whistleblower Doctor Claims Tamiflu Drug Fraud Bilked $1.5 Billion from Government to Stockpile Drug that is Ineffective in Stopping the Flu

Share it with your friends Like

Thanks! Share it with your friends!

Close

By AdminM

by Lanier Law Firm

BALTIMORE – Drug company Hoffmann-La Roche (OTCMKTS – RHHBY) bilked U.S. federal and state governments out of $1.5 billion by misrepresenting clinical studies and falsely claiming that its well-known influenza medicine Tamiflu was effective at containing potential pandemics, according to a recently unsealed whistleblower lawsuit.

The lawsuit claims the drugmaker’s scheme involved publishing misleading articles falsely stating that Tamiflu reduces complications, severity, hospitalizations, mortality and transmission of influenza. The company then used those articles to aggressively market the drug to the government for pandemic use. Relying on the supposed truthfulness …read more

Source: Health Impact News

    

  • Rating:
  • Views:99 views
  • Categories: Health